EL EssilorLuxottica SA

EssilorLuxottica’s third-quarter revenue - Keeping the high-single-digit pace, growing globally

EssilorLuxottica’s third-quarter revenue - Keeping the high-single-digit pace, growing globally

EssilorLuxottica’s third-quarter revenue

Keeping the high-single-digit pace, growing globally

  • Group’s revenue at Euro 6.4 billion, up 17.0%2 in Q3 versus 2021
  • +8.2%2 at constant exchange rates1 in third quarter
  • +8.8%2 at constant exchange rates1 in the first nine months



In Q3 at constant exchange rates1:

  • EMEA growing 9.2%2, North America up 3.4%2 on a tough comparison
  • Asia-Pacific and Latin America growing double digits
  • Comparable-store sales3 growing by 6.5%
  • E-commerce at 7% of total revenue, back to growth in Q3

Charenton-le-Pont, France (October 21, 2022 - 7:00 am) – EssilorLuxottica today announced that consolidated revenue for the third quarter of 2022 totaled Euro 6,394 million, representing a year-on-year increase of 8.2%2 at constant exchange rates1 compared to the third quarter of 2021 (+17.0%2 at current exchange rates).

Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “We are pleased with the solid performance our Company delivered in the third quarter of this year, with all the regions posting growth, from Asia-Pacific and Latin America, to EMEA and North America. The results once again demonstrate the power of our business model as well as the determination and agility of our almost 200,000 people worldwide, committed to the long term view we shared at our Capital Market Day this year.

Proving the impact we can have together, we earned the sixth spot on the Fortune Change the World list and celebrated World Sight Day by delivering vision care to more than 350,000 children and adults worldwide, all in the same week. We are a company that consistently delivers results and supports our communities, this ties into our commitment to growing the market for the benefit of all stakeholders.

Looking ahead, we remain confident in our strategic vision and our ability to deliver on our long-term outlook.”

Attachment



EN
21/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EssilorLuxottica SA

 PRESS RELEASE

EssilorLuxottica completes acquisition of Optegra

EssilorLuxottica completes acquisition of Optegra EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the from MidEuropa. Under the Optegra, Lexum and Iris brands, Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands. A natural fit for EssilorLuxottica’s expanding med-tech portfolio, this acquisition repres...

 PRESS RELEASE

EssilorLuxottica finalise l’acquisition d’Optegra

EssilorLuxottica finalise l’acquisition d’Optegra EssilorLuxottica finalise l’acquisition d’Optegra Paris, France (1er octobre 2025) – EssilorLuxottica annonce la finalisation de auprès de MidEuropa. Avec les marques Optegra, Lexum et Iris, Optegra est une plateforme d'ophtalmologie à forte croissance et hautement intégrée, opérant un vaste réseau de plus de 70 hôpitaux ophtalmologiques et centres de diagnostic dans cinq marchés européens clés : le Royaume-Uni, la République tchèque, la Pologne, la Slovaquie et les Pays-Bas. Très complémentaire avec le portefeuille med-tech d'EssilorLu...

 PRESS RELEASE

EssilorLuxottica completa l’acquisizione del gruppo Optegra

EssilorLuxottica completa l’acquisizione del gruppo Optegra EssilorLuxottica completa l’acquisizione del gruppo Optegra Parigi, Francia (1 ottobre 2025) – EssilorLuxottica annuncia di aver completato l’ da MidEuropa. Con i marchi Optegra, Lexum e Iris, il gruppo Optegra è una piattaforma oftalmica perfettamente integrata e in forte espansione. Attualmente opera una vasta rete di oltre 70 ospedali oftalmici e centri diagnostici in cinque mercati europei strategici: Regno Unito, Repubblica Ceca, Polonia, Slovacchia e Paesi Bassi. L’acquisizione si inserisce perfettamente nel portafoglio ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch